NPM1-rearranged AML: clinical features, molecular pathogenesis, and therapeutic perspectives
Yuko Shimosato, Susumu Goyama · 2026
Read NPM1-rearranged AML: clinical features, molecular pathogenesis, and therapeutic perspectives by Yuko Shimosato, Susumu Goyama (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13529867.txt.
Description
Shimosato and Goyama review a rare but instructive form of acute myeloid leukaemia driven by rearrangements of the NPM1 gene. The common NPM1 story is a small mutation found in up to two fifths of adult cases, with well-mapped behaviour. Rearrangements, where NPM1 fuses with partners such as MLF1 or RARA, are far rarer and were long neglected. Their 2026 synthesis gathers the emerging evidence on how these fusions look clinically and how they cause disease.
Reassuringly for drug developers, the fusions work through the same machinery as the common mutation. The NPM1 protein ends up stranded in the cytoplasm, partners with the export protein XPO1, and holds developmental HOX genes switched on, driving the leukaemia. Clinically, rearranged cases skew younger and may carry a worse outlook, though the authors flag the small numbers behind that claim.
Catalog record
| CREATOR | Yuko Shimosato, Susumu Goyama |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |